A/Prof Jeanne Tie is the lower gastrointestinal medical oncologythe study, diagnosis and treatment of cancer and trials lead at the Peter MacCallum Cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs Centre and senior research fellow in the Personalised Oncology Division at the Walter and Eliza Hall Institute of Medical Research. Her translational research focusses on personalising treatment for patients with colorectalrelating to the colon or rectum in the large bowel/intestine cancer with prognostic and predictive biomarkers, in particular the clinical applications of circulating tumoura tissue mass that forms from groups of unhealthy cells DNA (ctDNA). She leads several ctDNA-based randomized clinical trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases in colorectal cancer which aim to assess the clinical utility of ctDNA in guiding adjuvant treatment decision.
A/Prof Tie’s clinical trial work focusses on evaluating new treatment for patients with colorectal cancer. She serves or has served on the Australasian Gastrointestinal Trials Group (AGITG) Scientific Advisory Committee and Lower GI working party, Cancer Adjudication Committee for the ASPREE (Aspirin in Reducing Events in the Elderly) International study, ESMO (European Society for Medical Oncology) Gastro-Intestinal Tumours Faculty, American Society of Clinical Oncology (ASCO) Education Faculty and ESMO Asia Congress Gastrointestinal Track Co-Chair.
Location
305 Grattan Street, Melbourne VIC, Australia
